These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 28161619)

  • 1. Combination of metformin with chemotherapeutic drugs via different molecular mechanisms.
    Peng M; Darko KO; Tao T; Huang Y; Su Q; He C; Yin T; Liu Z; Yang X
    Cancer Treat Rev; 2017 Mar; 54():24-33. PubMed ID: 28161619
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination chemotherapy of the taxanes and antimetabolites: its use and limitations.
    Smorenburg CH; Sparreboom A; Bontenbal M; Verweij J
    Eur J Cancer; 2001 Dec; 37(18):2310-23. PubMed ID: 11720823
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Gemcitabine and breast cancer].
    Besse B; Spano JP
    Bull Cancer; 2002 Aug; 89 Spec No():S107-14. PubMed ID: 12449040
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of gemcitabine in the treatment of advanced and metastatic breast cancer.
    Heinemann V
    Oncology; 2003; 64(3):191-206. PubMed ID: 12697958
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Additive growth inhibition after combined treatment of 2-methoxyestradiol and conventional chemotherapeutic agents in human pancreatic cancer cells.
    Fotopoulou C; Baumunk D; Schmidt SC; Schumacher G
    Anticancer Res; 2010 Nov; 30(11):4619-24. PubMed ID: 21115915
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current and future perspectives in advanced bladder cancer: is there a new standard?
    von der Maase H
    Semin Oncol; 2002 Feb; 29(1 Suppl 3):3-14. PubMed ID: 11894002
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Paclitaxel combination therapy in the treatment of metastatic breast cancer: a review.
    Holmes FA
    Semin Oncol; 1996 Oct; 23(5 Suppl 11):46-56. PubMed ID: 8893900
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Future directions in the chemotherapy of ovarian cancer.
    Ozols RF
    Semin Oncol; 1997 Oct; 24(5 Suppl 15):S15-86-S15-90. PubMed ID: 9346230
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biweekly paclitaxel and gemcitabine for patients with advanced urothelial cancer ineligible for cisplatin-based regimen.
    Takahashi T; Higashi S; Nishiyama H; Segawa T; Nakamura E; Kinoshita H; Itoh N; Yamamoto S; Kamoto T; Habuchi T; Ogawa O
    Jpn J Clin Oncol; 2006 Feb; 36(2):104-8. PubMed ID: 16418182
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metformin-induced alterations in nucleotide metabolism cause 5-fluorouracil resistance but gemcitabine susceptibility in oesophageal squamous cell carcinoma.
    Mynhardt C; Damelin LH; Jivan R; Peres J; Prince S; Veale RB; Mavri-Damelin D
    J Cell Biochem; 2018 Jan; 119(1):1193-1203. PubMed ID: 28722177
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The update on pancreatic cancer chemotherapy].
    Brasiūniene B; Juozaityte E; Brasiūnas V; Inciūra A
    Medicina (Kaunas); 2003; 39(10):1016-25. PubMed ID: 14578647
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metformin potentiates the anticancer activities of gemcitabine and cisplatin against cholangiocarcinoma cells in vitro and in vivo.
    Zhu HQ; Ma JB; Song X; Gao HJ; Ma CQ; Chang H; Li HG; Liu FF; Lu J; Zhou X
    Oncol Rep; 2016 Dec; 36(6):3488-3496. PubMed ID: 27779693
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systemic chemotherapy of transitional cell carcinoma of the urothelium.
    Brinkley WM; Torti FM
    Semin Surg Oncol; 1997; 13(5):365-75. PubMed ID: 9259093
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravenous 3-weekly paclitaxel and metronomic oral cyclophosphamide in patients with advanced urothelial cancer previously treated with gemcitabine and platinum.
    Park JH; Lee JL
    Cancer Chemother Pharmacol; 2015 Feb; 75(2):247-54. PubMed ID: 25428517
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gemcitabine in the treatment of ovarian cancer.
    Hansen SW; Tuxen MK; Sessa C
    Ann Oncol; 1999; 10 Suppl 1():51-3. PubMed ID: 10219453
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gemcitabine for unresectable, locally advanced or metastatic bladder cancer.
    Shelley M; Cleves A; Wilt TJ; Mason M
    Cochrane Database Syst Rev; 2011 Apr; (4):CD008976. PubMed ID: 21491413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Gemcitabine: a new chemotherapy agent for solid cancers].
    Klastersky J; Awada A
    Rev Med Brux; 1997 Oct; 18(5):328-34. PubMed ID: 9441329
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gemcitabine combination chemotherapy in metastatic breast cancer: phase II experience.
    O'Shaughnessy J
    Oncology (Williston Park); 2003 Dec; 17(12 Suppl 14):15-21. PubMed ID: 14768400
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [New developments in chemotherapy for metastasized bladder cancer].
    de Wit R
    Ned Tijdschr Geneeskd; 2001 Dec; 145(50):2412-7. PubMed ID: 11776665
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Chemotherapy of stage IV non-small-cell lung cancer: contribution of gemcitabine].
    Souquet PJ; Gérinière L
    Rev Pneumol Clin; 2000 Nov; 56(5):315-9. PubMed ID: 11139761
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.